FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / memo-analysis-meridian-term-sheet.docx
memo-analysis-meridian-term-sheet.docx · 1025-00008

Parties

HARKNESS LLP
Quorum Insurance Holdings Corp
Ashe LLP
Strauss LLP
Pinnacle Ridge Advisory LLC

Dates

September 16, 2022
September 12, 2022
December 31, 2022
August 15, 2022

Amounts

$60,000,000
$10,800,000
$12,300,000
$1,500,000
$4.18
$8.9
$1.42
$438
$40
$50

Obligations

Quorum should consider negotiating a right of first offer or preferential pricing on new Meridian data products introduced during the initial term, to avoid a situation in which Quorum must negotiate separate license terms for new data feeds that complement or extend the currently licensed products
The MFN clause would provide that Meridian shall not offer any member of the Comparable Licensee Class an effective per-record rate, volume discount, or aggregate annual fee more favorable than the corresponding rate, discount, or fee provided to Quorum, and that if Meridian offers more favorable terms to any Comparable Licensee, Quorum's pricing shall be automatically adjusted to match the more favorable terms on a going-forward basis
The Term Sheet provides that Meridian shall have sole discretion to determine whether any particular item of Derived Data meets the "sufficient transformation" standard, and that Quorum must submit all Derived Data intended for external commercialization to Meridian for review and approval prior to distribution
This technical distinction is critical and must be addressed in Quorum's counter-term sheet with precision
The Term Sheet provides that the MDLA shall be governed by the laws of the State of New York, without regard to its conflicts-of-law principles
Quorum should negotiate the right to sublicense the Licensed Data Products to its wholly-owned subsidiaries and affiliates (as defined in the MDLA, which should track Quorum's corporate structure) without the requirement of Meridian's prior written consent, provided that each sublicensee agrees to be bound by the terms and conditions of the MDLA